Shenzhen New Industries Biomedical Engineering Co., Ltd.
SZSE:300832.SZ
60.24 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 1,048.265 | 483.426 | 617.58 | 1,074.606 | 1,980.045 | 1,431.385 | 1,081.725 | 898.6 | 506.204 | 250.541 | 209.248 | 160.598 |
| Short Term Investments
| 2,355.97 | 2,813.667 | 2,806.483 | 2,300.112 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 3,128.447 | 3,297.094 | 3,424.063 | 3,374.718 | 1,980.045 | 1,431.385 | 1,081.725 | 898.6 | 506.204 | 250.541 | 209.248 | 160.598 |
| Net Receivables
| 631.782 | 479.965 | 276.098 | 218.351 | 227.681 | 203.92 | 188.511 | 171.39 | 138.646 | 96.035 | 65.968 | 32.669 |
| Inventory
| 916.788 | 839.329 | 645.376 | 459.287 | 236.773 | 194.412 | 143.087 | 121.61 | 113.003 | 89.257 | 75.499 | 81.071 |
| Other Current Assets
| 111.197 | 200.135 | 147.526 | 69.292 | 34.09 | 34.295 | 21.735 | 20.798 | 23.065 | 24.394 | 7.748 | 15.32 |
| Total Current Assets
| 5,064.002 | 4,822.392 | 4,497.147 | 4,124.924 | 2,484.876 | 1,866.64 | 1,435.058 | 1,205.618 | 771.832 | 449.302 | 358.462 | 289.658 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 1,446.643 | 1,325.473 | 1,134.298 | 803.509 | 568.871 | 622.542 | 506.031 | 317.021 | 312.996 | 285.326 | 53.712 | 14.407 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 169.457 | 172.476 | 94.563 | 98.914 | 102.591 | 55.281 | 57.429 | 59.104 | 58.751 | 5.516 | 5.626 | 5.526 |
| Goodwill and Intangible Assets
| 169.457 | 172.476 | 94.563 | 98.914 | 102.591 | 55.281 | 57.429 | 59.104 | 58.751 | 5.516 | 5.626 | 5.526 |
| Long Term Investments
| 1,347.758 | -2,456.044 | -2,669.583 | 206.183 | 215.971 | 4.591 | 4.474 | 1.27 | 0 | 0 | 2.248 | 0 |
| Tax Assets
| 37.935 | 22.897 | 12.139 | 22.729 | 8.253 | 6.034 | 3.858 | 2.748 | 1.844 | 1.249 | 1.048 | 0.683 |
| Other Non-Current Assets
| 156.694 | 3,127.359 | 3,066.944 | 49.435 | 77.153 | 85.712 | 15.38 | 19.256 | 2.656 | 4.042 | 119.866 | 2.833 |
| Total Non-Current Assets
| 3,158.487 | 2,192.162 | 1,638.36 | 1,180.769 | 972.84 | 774.16 | 587.171 | 399.399 | 376.247 | 296.133 | 182.501 | 23.449 |
| Total Assets
| 8,222.489 | 7,014.554 | 6,135.508 | 5,305.694 | 3,457.716 | 2,640.8 | 2,022.229 | 1,605.017 | 1,148.078 | 745.435 | 540.963 | 313.107 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 126.986 | 176.68 | 171.354 | 98.263 | 54.172 | 62.561 | 81.091 | 15.344 | 12.562 | 27.694 | 23.579 | 13.139 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 120.355 | 79.476 | 69.946 | 104.088 | 75.548 | 66.684 | 60.891 | 60.562 | 32.546 | 38.403 | 19.883 | 10.386 |
| Deferred Revenue
| 91.478 | 108.943 | 331.518 | 71.056 | 43.371 | 32.746 | 26.913 | 0 | 0 | 0 | 39.014 | 0 |
| Other Current Liabilities
| 252.662 | 218.844 | -64.883 | 219.336 | 178.65 | 134.936 | 97.178 | 83.203 | 62.285 | 45.57 | 40.086 | 22.467 |
| Total Current Liabilities
| 591.48 | 583.943 | 507.935 | 492.744 | 308.37 | 264.18 | 239.16 | 159.109 | 107.392 | 111.668 | 83.548 | 45.992 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 3.494 | 0.893 | 0.881 | 1.195 | 0 | 0 | 0 | 0 | 0 | 0 | 51.38 | 0 |
| Deferred Revenue Non-Current
| 0 | 5.811 | 6.579 | 8.742 | 10.553 | 10.34 | 10.84 | 26.64 | 17.552 | 23.252 | 27.192 | 0 |
| Deferred Tax Liabilities Non-Current
| 50.056 | 24.413 | 8.114 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -27.192 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | -1.195 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.94 |
| Total Non-Current Liabilities
| 53.55 | 31.117 | 15.574 | 8.742 | 10.553 | 10.34 | 10.84 | 26.64 | 17.552 | 23.252 | 78.572 | 18.94 |
| Total Liabilities
| 645.031 | 615.06 | 523.509 | 501.486 | 318.923 | 274.521 | 250 | 185.749 | 124.944 | 134.92 | 162.12 | 64.932 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 785.719 | 786.126 | 786.659 | 412.35 | 370.4 | 370.4 | 370.4 | 370.4 | 370.4 | 106 | 106 | 106 |
| Retained Earnings
| 4,980.743 | 3,874.345 | 3,108.513 | 2,643.644 | 2,343.997 | 1,571.388 | 993.638 | 694.457 | 343.492 | 373.685 | 167.3 | 50.759 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 496.664 | 453.383 | 394.598 | 476.22 | 424.492 | 408.191 | 0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 1,777.939 | 1,739.023 | 1,716.826 | 1,748.539 | 424.396 | 424.476 | 408.191 | 354.412 | 309.242 | 130.83 | 105.543 | 91.416 |
| Total Shareholders Equity
| 7,544.4 | 6,399.495 | 5,611.999 | 4,804.208 | 3,138.793 | 2,366.279 | 1,772.229 | 1,419.269 | 1,023.134 | 610.515 | 378.843 | 248.175 |
| Total Equity
| 7,544.4 | 6,399.495 | 5,611.999 | 4,804.208 | 3,138.793 | 2,366.279 | 1,772.229 | 1,419.269 | 1,023.134 | 610.515 | 378.843 | 248.175 |
| Total Liabilities & Shareholders Equity
| 8,222.489 | 7,014.554 | 6,135.508 | 5,305.694 | 3,457.716 | 2,640.8 | 2,022.229 | 1,605.017 | 1,148.078 | 745.435 | 540.963 | 313.107 |